Borellini Flavia reported option exercise involving 2,500 derivative units of Revolution Medicines, Inc. at $0.00 for $0 on Nov 13, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Director
DIR
Filed Nov 17, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
2,500Stock Option (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
13,455Direct
Trade date
Nov 13, 2026Option exercise
Filed
Nov 17, 2026, 6:00 PM ET4-day reporting delay
Accession
0001193125-26-465795Code M · Transaction 404401
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 13, 2026Option exercise2,500$37.54$93,850Trade 404400
2 transaction rows in this filing. Joint filers share the same rows.

RVMD price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
RVMD · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 24, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +19%1w ago +18%1d ago +8.4%
Returns since7d30d90d180d1y

Footnotes in full

F1: Includes 1,191 restricted stock units. F2: Fully vested.